arrow
N

Nacho Aguiló

facultad de medicina
H指数:34
被引数:3,594

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

活减毒分枝杆菌结核疫苗,MTBVAC,在有无Mycobacterium tuberculosis致敏的成人中的研究:一项单中心、1b~2a期、双盲、剂量递增、随机对照试验

2025-04-150
OAAI
Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

MTBVAC在婴儿中的安全性、反应原性和免疫原性:一项在结核病流行地区进行的2a期随机、双盲、剂量定义试验

2025-04-010
PRE
Correlation between systemic allergen desensitisation and long-term asthma protection in mice following intravenous administration of the live tuberculosis vaccine MTBVAC (vol 107, 105272, 2024)

系统性过敏原脱敏与MTBVAC(活结核疫苗)静脉注射后小鼠长期哮喘保护作用之间的相关性(卷107,105272,2024)

2025-03-010
OAAI
Safety, reactogenicity and immunogenicity of MTBVAC in newborns in a TB endemic area: a phase 2a randomized, double-blind, dose-defining trial
2023-12-170
OA
Intravenous administration of BCG in mice promotes natural killer and T cell-mediated antitumor immunity in the lung
2023-10-0410
OAAI
The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy

结核分枝杆菌PhoPR毒力系统调节通用第二信使c-di-amp的表达并影响疫苗的安全性和有效性

2022-03-0112
OAAI
Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2

确定针对刺突受体结合域的IgG浓度,该浓度可预测恢复期血浆和血清对SARS-CoV-2的病毒中和活性

2021-03-1017
OAAI
Stronger induction of trained immunity by mucosal BCG or MTBVAC vaccination compared to standard intradermal vaccination

与标准皮内疫苗接种相比,粘膜BCG或MTBVAC疫苗接种对训练免疫的诱导作用更强

2021-01-0152
OAAI